Global Research and Development, SMPS, Genentech Inc., 1 DNA Way, South San Francisco, California 4080, USA.
AAPS PharmSciTech. 2012 Jun;13(2):713-22. doi: 10.1208/s12249-012-9795-2. Epub 2012 May 5.
It is well recognized that poor dissolution rate and solubility of drug candidates are key limiting factors for oral bioavailability. While numerous technologies have been developed to enhance solubility of the drug candidates, poor water solubility continuously remains a challenge for drug delivery. Among those technologies, amorphous solid dispersions (SD) have been successfully employed to enhance both dissolution rate and solubility of poorly water-soluble drugs. This research reports a high-throughput screening technology developed by utilizing a 96-well plate system to identify optimal drug load and polymer using a solvent casting approach. A minimal amount of drug was required to evaluate optimal drug load in three different polymers with respect to solubility improvement and solid-state stability of the amorphous drug-polymer system. Validation of this method was demonstrated with three marketed drugs as well as with one internal compound. Scale up of the internal compound SD by spray drying further confirmed the validity of this method, and its quality was comparable to a larger scale process. Here, we demonstrate that our system is highly efficient, cost-effective, and robust to evaluate the feasibility of spray drying technology to produce amorphous solid dispersions.
人们普遍认识到,药物候选物的溶解速率和溶解度差是口服生物利用度的关键限制因素。虽然已经开发出许多技术来提高候选药物的溶解度,但较差的水溶性仍然是药物输送的一个挑战。在这些技术中,无定形固体分散体(SD)已成功用于提高水溶性差的药物的溶解速率和溶解度。本研究报告了一种高通量筛选技术,该技术利用 96 孔板系统,通过溶剂浇铸法来确定最佳的药物载药量和聚合物。仅需少量药物即可评估三种不同聚合物中最佳的药物载药量,以提高药物的溶解度和无定形药物-聚合物体系的固体稳定性。该方法通过喷雾干燥对三种市售药物和一种内部化合物进行了验证,进一步证实了该方法的有效性,其质量与大规模工艺相当。在这里,我们证明了我们的系统是高效、经济高效且稳健的,可以评估喷雾干燥技术生产无定形固体分散体的可行性。